Skip to content

ARDSnet Protocol vs. Open Lung Approach in ARDS

ARDSnet Protocol vs. the Open Lung Approach for the Ventilatory Management of Severe, Established ARDS: A Global Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00431158
Enrollment
224
Registered
2007-02-05
Start date
2007-01-31
Completion date
2013-03-31
Last updated
2014-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Distress Syndrome, Adult

Keywords

Acute Respiratory Distress Syndrome, ARDS, Respiratory failure, Mechanical Ventilation, Positive end expiratory pressure, Lung recruitment maneuver

Brief summary

Many patients with Acute Respiratory Distress Syndrome or ARDS need breathing support that is provided by a machine called a ventilator or respirator. The purpose of this study is to find out if a new method of setting the ventilator for patients with severe ARDS is better than the standard, commonly used way of setting the ventilator.

Detailed description

The ARDSnet protocol is the current, standard of care for ARDS. Mechanical ventilation is managed using low tidal volumes, relatively high respiratory rates, with oxygenation managed according to PEEP and FIO2 relationships as defined in a table. This study compares the ARDSnet protocol with an open lung approach to mechanical ventilation. The open lung approach uses a technique to recruit collapsed lung areas and then uses the lowest PEEP level that prevents recollapse of recruited lung units. The best PEEP level is determined by a decremental PEEP trial involving a series of pressure measurements taken after the recruitment maneuver. Both the ARDSnet protocol and the open lung approach require low tidal volumes and plateau pressures. Evidence suggests that using a mechanical ventilation strategy of recruitment maneuvers (to open the collapsed lung) followed by high PEEP (to prevent collapse of the opened lung) with control of transpulmonary pressure through lower plateau pressures would maximize homogeneity within the lung and as such, minimize shearing forces in the lung parenchyma, thus improving ventilation and outcome in mechanically ventilated ARDS patients.

Interventions

OTHERDifferent Mechanical Ventilation Protocols

OLA Group: Open lung approach protocol and recruitment maneuvers ARDSnet Group: ARDSnet protocol

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Intubated and mechanically ventilated * Diagnosis of ARDS using American-European consensus criteria * Enrollment in study \< 48 hours since diagnosis of ARDS * For 12-36 hrs. (ideally 12-24 hrs) after diagnosis of ARDS, patient must be ventilated as follows: Volume A/C, Tidal volume of 4-8 ml/kg PBW, Plateau pressure ≤ 30 cmH2O, PEEP/FIO2 adjustments using ARDSnet table, Ventilator rate to keep PaCO2 = 35-60 mmHg * During the 12-36 hour(ideally 12-24 hr) period, PaO2/FIO2 must remain \< 200 mm Hg for an ABG obtained 30 minutes after placement on the following specific ventilator settings: Volume A/C, Tidal volume = 6 ml/kg PBW, Plateau pressure ≤ 30 cmH2O, Inspiratory time ≤ 1 second, PEEP ≥ 10 cmH2O, FIO2 ≥ 0.5, Ventilator rate to keep PaCO2 = 35-60 mmHg * No lung recruitment maneuvers or adjunct therapy. * Total time on mechanical ventilation \< 96 hrs. at time of randomization.

Exclusion criteria

* Age \< 18 years or \> 80 years * Weight \< 35 kg PBW * Body mass index \> 60 * Intubated 2° to acute exacerbation of a chronic pulmonary disease * Acute brain injury (ICP \> 18 mmHg) * Immunosuppression 2° to chemo- or radiation therapy * Severe cardiac disease(one of the following): New York Heart Association Class 3 or 4, acute coronary syndrome or persistent ventricular tachyarrhythmias * Positive laboratory pregnancy test * Sickle cell disease * Neuromuscular disease * High risk of mortality within 3 months from cause other than ARDS, e.g. cancer * More than 2 organ failures (not including pulmonary system) * Documented lung barotrauma, i.e. chest tube placement other than for fluid drainage * Persistent hemodynamic instability or intractable shock * Penetrating chest trauma * Enrollment in another interventional study

Design outcomes

Primary

MeasureTime frame
60 day mortality60 days

Secondary

MeasureTime frame
Hospital mortalityDuration of hospital stay
28 day mortality28 days
180 day mortality180 days
365 day mortality365 days
Ventilator free daysHospital stay
Length of ICU stayDuration of ICU stay
Development of extra-pulmonary organ failuresDuration of hospital stay
ICU mortalityDuration of ICU stay
Incidence of barotraumaDuration of hospital stay
Systemic inflammatory mediator levelsDuration of hospital stay
Lung function 6 months after discharge6 months
Lung function 12 months after discharge12 months
Need for rescue therapyDuration of hospital stay
Ventilation associated pneumonia rateDuration of hospital stay
Duration of hospitalizationDuration of hospital stay

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026